CORC  > 河南大学
Gefitinib single drug in treatment of advanced esophageal cancer
Xu Yingjun[1]; Xie Zhihui[2]; Shi Yan[3]; Zhang Mengwei[4]; Pan Jia[5]; Li Yanming[6]; Lu Hong[7]
刊名JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
2016
卷号12期号:8页码:295-297
关键词Clinical efficacy esophageal cancer gefitinib prognosis toxicity
ISSN号0973-1482
DOIhttp://dx.doi.org/10.4103/0973-1482.200760
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/5195951
专题河南大学
作者单位1.[1]Department of Oncology, Huaihe Hospital of Henan University, Kaifeng, Henan, P.R. China.
2.[2]Department of Oncology, Huaihe Hospital of Henan University, Kaifeng, Henan, P.R. China.
3.[3]Department of Oncology, Huaihe Hospital of Henan University, Kaifeng, Henan, P.R. China.
4.[4]Department of Oncology, Huaihe Hospital of Henan University, Kaifeng, Henan, P.R. China.
5.[5]Department of Oncology, Huaihe Hospital of Henan University, Kaifeng, Henan, P.R. China.
6.[6]Department of Oncology, Huaihe Hospital of Henan University, Kaifeng, Henan, P.R. China.
7.[7]Department of Oncology, Huaihe Hospital of Henan University, Kaifeng, Henan, P.R. China.
推荐引用方式
GB/T 7714
Xu Yingjun[1],Xie Zhihui[2],Shi Yan[3],et al. Gefitinib single drug in treatment of advanced esophageal cancer[J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS,2016,12(8):295-297.
APA Xu Yingjun[1].,Xie Zhihui[2].,Shi Yan[3].,Zhang Mengwei[4].,Pan Jia[5].,...&Lu Hong[7].(2016).Gefitinib single drug in treatment of advanced esophageal cancer.JOURNAL OF CANCER RESEARCH AND THERAPEUTICS,12(8),295-297.
MLA Xu Yingjun[1],et al."Gefitinib single drug in treatment of advanced esophageal cancer".JOURNAL OF CANCER RESEARCH AND THERAPEUTICS 12.8(2016):295-297.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace